Abstract
The present work involves the synthesis of a series of new disulfides linked to 1,2,4-triazole bearing urea moiety through multistep reaction. The in vitro cytotoxicity of the compounds in three human cancer cell lines (SMMC-7721, A549, Hela) and one normal cell line (L929) was evaluated via CCK-8 assay. Among the synthesized compounds, 3-(4-fluorophenylcarbamoylamino)-5-(n-butyldi-sulfanyl)-1,2,4-triazole (7c) was found to have the greatest antiproliferative activity against SMMC-7721 cells (IC50 = 1.10 µM) and showed better activity than the lead compound (PX-12, IC50 = 4.05 µM) and the reference drug (5-FU, IC50 = 5.62 µM) did. The IC50 value of 7c in L929 cells was 13.4 times higher than that in the SMMC-7721 cells. Therefore, compound 7c exhibited better potency and specificity compared with PX-12 and 5-FU, and was identified as a promising anticancer lead compound for further development.
Graphical Abstract
Similar content being viewed by others
References
Bhatt P, Kumar M, Jha A. Synthesis, docking and anticancer activity of azo-linked hybrids of 1,3,4-thia-/oxadiazoles with cyclic imides. Mol Divers. 2018;22:827–40. https://doi.org/10.1007/s11030-018-9832-5
Chowrasia D, Karthikeyan C, Choure L, Sahabjada, Gupta M, Arshad M, et al. Synthesis, characterization and anticancer activity of some fluorinated 3,6-diaryl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles. Arab J Chem. 2017;10:S2424–8. https://doi.org/10.1016/j.arabjc.2013.08.026
Rostom SAF, Badr MH, El Razik HAA, Ashour HMA. Structure-based development of novel triazoles and related thiazolotriazoles as anticancer agents and Cdc25A/B phosphatase inhibitors. Synthesis, in vitro biological evaluation, molecular docking and in silico ADME-T studies. Eur J Med Chem. 2017;139:263–79. https://doi.org/10.1016/j.ejmech.2017.07.053
Ragab FAF, Abou-Seri SM, Abdel-Aziz SA, Alfayomy AM, Aboelmagd M. Design, synthesis and anticancer activity of new monastrol analogues bearing 1,3,4-oxadiazole moiety. Eur J Med Chem. 2017;138:140–51. https://doi.org/10.1016/j.ejmech.2017.06.026
Sahi S, Sodhi RK, Jamwal B, Paul S. Synthesis and in vitro biological evaluation of some novel triazole-based heterocycles aspotential antimicrobial agents. J Heterocyclic Chem. 2018;55:1596–603. https://doi.org/10.1002/jhet.3193
Pachuta-Stec A, Biernasiuk A, Malm A, Pitucha M. Synthesis and antimicrobial evaluation of novel derivatives of semicarbazide and 1,2,4-triazole. J Heterocyclic Chem. 2017;54:2867–73. https://doi.org/10.1002/jhet.2893
El-Serwy WS, Mohamed NA, Abbas EM, Abdel-Rahman RF. Synthesis and anti-inflammatory properties of novel 1,2,4-triazole derivatives. Res Chem Intermed. 2013;39:2543–54. https://doi.org/10.1007/s11164-012-0781-9
Ahirwar J, Ahirwar D, Lanjhiyana S, Jha AK, Dewangan D, Badwaik H. Analgesic and anti-inflammatory potential of merged pharmacophore containing 1,2,4-triazoles and substituted benzyl groups via thio linkage. J Heterocyclic Chem. 2018;55:2130–41. https://doi.org/10.1002/jhet.3258
Cao XF, Wang W, Wang SS, Bao LZ. Asymmetric synthesis of novel triazole derivatives and their in vitro antiviral activity and mechanism of action. Eur J Med Chem. 2017;139:718–25. https://doi.org/10.1016/j.ejmech.2017.08.057
Maarouf AR, Farahat AA, Selim KB, Eisa HM. Synthesis and antiviral activity of benzimidazolyl- and triazolyl-1,3,5-triazines. Med Chem Res. 2012;21:703–10. https://doi.org/10.1007/s00044-011-9574-8
Padmaja A, Pedamalakondaiah D, Sravya G, Reddy GM, Kumar MVJ. Synthesis and antioxidant activity of a new class of sulfone/sulfonamide-linked bis(oxadiazoles), bis(thiadiazoles), and bis(triazoles). Med Chem Res. 2015;24:11–20. https://doi.org/10.1007/s00044-014-1277-5
Aktas-Yokus O, Yuksek H, Gursoy-Kol O, Alpay-Karaoglu S. Synthesis and biological evaluation of new 1,2,4-triazole derivatives with their potentiometric titrations. Med Chem Res. 2015;24:2813–24. https://doi.org/10.1007/s00044-015-1334-8
Abuelhassan AH, Badran MM, Hassan HA, Abdelhamed D, Elnabtity S, Aly OM. Design, synthesis, anticonvulsant activity, and pharmacophore study of new 1,5-diaryl-1H-1,2,4-triazole-3-carboxamide derivatives. Med Chem Res. 2018;27:928–38. https://doi.org/10.1007/s00044-017-2114-4
Plech T, Kaproń B, Łuszczki JJ, Paneth A, Siwek A, Kołaczkowski M, et al. Studies on the anticonvulsant activity of 4-alkyl-1,2,4-triazole-3-thiones and their effect on GABAergic system. Eur J Med Chem. 2014;86:690–9. https://doi.org/10.1016/j.ejmech.2014.09.034
Chelamalla R, Akena V, Manda S. Synthesis of N’-arylidene-2-(5-aryl-1H-1,2,4- triazol-3-ylthio) acetohydrazides as antidepressants. Med Chem Res. 2017;26:1359–66. https://doi.org/10.1007/s00044-017-1854-5
Nikitina IL, Gabidullin RA, Klen EE, Tyurina LA, Alekhin EK, Khaliullin FA. Computer analysis of the structure-antidepressant activity relationship in series of 1,2,4-triazole and thietane-1,1-dioxide derivatives. Pharm Chem J. 2012;46:213–8. https://doi.org/10.1007/s11094-012-0764-6
Miniyar PB, Mahajan AA, Mokale SN, Shah MU, Kumar AS, Chaturbhuj GU. Triazole hybrids as new type of anti-fungal agents. Arab J Chem. 2017;10:295–9. https://doi.org/10.1016/j.arabjc.2013.09.005
Jin RY, Liu JL, Zhang GH, Li JJ, Zhang S, Guo H. Design, synthesis, and antifungal activities of novel 1,2,4-triazole schiff base derivatives. Chem Biodivers. 2018;15:e1800263 https://doi.org/10.1002/cbdv.201800263
Sun XQ, Hong ZX, Liu MY, Guo S, Yang D, Wang Y, et al. Design, synthesis, and biological activity of novel tetrahydropyrazolopyridone derivatives as FXa inhibitors with potent anticoagulant activity. Bioorg Med Chem. 2017;25:2800–10. https://doi.org/10.1016/j.bmc.2017.03.055
El-Saghier AM, Mohamed MA, Abd-Allah OA, Kadry AM, Ibrahim TM, Bekhit AA. Green synthesis, antileishmanial activity evaluation, and in silico studies of new amino acid-coupled 1,2,4-triazoles. Med Chem Res. 2019;28:169–81. https://doi.org/10.1007/s00044-018-2274-x
Karaali N, Aydin S, Baltas N, Mentese E. Synthesis of novel tetra-substituted benzimidazole compounds containing certain heterostructures with antioxidant and anti-urease activities. J Heterocyclic Chem. 2020;57:1806–15. https://doi.org/10.1002/jhet.3905
Shen QK, Liu CF, Zhang HJ, Tian YS, Quan ZS. Design and synthesis of new triazoles linked to xanthotoxin for potent and highly selective anti-gastric cancer agents. Bioorg Med Chem Lett. 2017;27:4871–5. https://doi.org/10.1016/j.bmcl.2017.09.040
Cai H, Huang XJ, Xu ST, Shen H, Zhang PF, Huang Y, et al. Discovery of novel hybrids of diaryl-1,2,4-triazoles and caffeic acid as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase for cancer therapy. Eur J Med Chem. 2016;108:89–103. https://doi.org/10.1016/j.ejmech.2015.11.013
Kulabaş N, Tatar E, Özakpınar ÖB, Özsavcı D, Pannecouque C, Clercq ED, et al. Synthesis and antiproliferative evaluation of novel 2-(4H-1,2,4-triazole-3-ylthio)acetamide derivatives as inducers of apoptosis in cancer cells. Eur J Med Chem. 2016;121:58–70. https://doi.org/10.1016/j.ejmech.2016.05.017
Roldán-Peña JM, Alejandre-Ramos D, López Ó, Maya I, Lagunes I, Padrón JM, et al. New tacrine dimers with antioxidant linkers as dual drugs: Anti-Alzheimer’s and antiproliferative agents. Eur J Med Chem. 2017;138:761–73. https://doi.org/10.1016/j.ejmech.2017.06.048
Sheppard JG, Frazier KR, Saralkar P, Hossain MF, Geldenhuys WJ, Long TE. Disulfiram-based disulfides as narrow-spectrum antibacterial agents. Bioorg Med Chem Lett. 2018;28:1298–302. https://doi.org/10.1016/j.bmcl.2018.03.023
Branowska D, Ławecka J, Sobiczewski M, Karczmarzyk Z, Wysocki W, Wolińska E, et al. Synthesis of unsymmetrical disulfanes bearing 1,2,4-triazine scaffold and their in vitro screening towards anti-breast cancer activity. Monatsh Chem. 2018;149:1409–20. https://doi.org/10.1007/s00706-018-2206-y
Jadhav KB, Stein C, Makarewicz O, Pradel G, Lichtenecker RJ, Sack H, et al. Bioactivity of topologically confined gramicidin A dimmers. Bioorg Med Chem. 2017. 2017;25:261–8. https://doi.org/10.1016/j.bmc.2016.10.033
Diraimondo TR, Plugis NM, Jin X, Khosla C. Selective inhibition of extracellular thioredoxin by asymmetric disulfides. J Med Chem. 2013;56:1301–10. https://doi.org/10.1021/jm301775s
Baker AF, Adab KN, Raghunand N, Chow HHS, Stratton SP, Squire SW, et al. A phase IB trial of 24-hour intravenous PX-12, a thioredoxin-1 inhibitor, inpatients with advanced gastrointestinal cancers. Invest New Drugs. 2013;31:631–41. https://doi.org/10.1007/s10637-012-9846-2
You BR, Shin HR, Park WH. PX-12 inhibits the growth of A549 lung cancer cells via G2/M phase arrest and ROS-dependent apoptosis. Int J Oncol. 2014;44:301–8. https://doi.org/10.3892/ijo.2013.2152
Hroch L, Benek O, Guest P, Aitken L, Soukup O, Janockova J, et al. Design, synthesis and in vitro evaluation of benzothiazole-based ureas as potential ABAD/17b-HSD10 modulators for Alzheimer’s disease treatment. Bioorg Med Chem Lett. 2016;26:3675–8. https://doi.org/10.1016/j.bmcl.2016.05.087
Patil-Sen Y, Dennison SR, Snape TJ. Functional foldamers that target bacterial membranes: the effect of charge, amphiphilicity and conformation. Bioorg Med Chem. 2016;24:4241–5. https://doi.org/10.1016/j.bmc.2016.07.017
Benmansour F, Trist I, Coutard B, Decroly E, Querat G, Brancale A, et al. Discovery of novel dengue virus NS5 methyltransferase non-nucleoside inhibitors by fragment-based drug design. Eur J Med Chem. 2017;125:865–80. https://doi.org/10.1016/j.ejmech.2016.10.007
Zhang HQ, Gong FH, Ye JQ, Zhang C, Yue XH, Li CG. Design and discovery of 4-anilinoquinazoline-urea derivatives as dual TK inhibitors of EGFR and VEGFR-2. Eur J Med Chem. 2017;125:245–54. https://doi.org/10.1016/j.ejmech.2016.09.039
Qin M, Yan S, Wang L, Zhang HT, Zhao YF, Wu SS. Discovery of novel diaryl urea derivatives bearing a triazole moiety as potential antitumor agents. Eur J Med Chem. 2016;115:1–13. https://doi.org/10.1016/j.ejmech.2016.02.071
Zuo SJ, Zhang S, Mao S, Xie XX, Xiao X, Xin MH, et al. Combination of 4-anilinoquinazoline, arylurea and tertiary amine moiety to discover novel anticancer agents. Bioorg Med Chem. 2016;24:179–90. https://doi.org/10.1016/j.bmc.2015.12.001
Wu Z, Li X, Chi CL, Xu L, Sun YY, Chen BQ. Synthesis and antitumor effects of a new class of 1,2,4-triazole derivatives. Med Chem Res. 2021;30:142–51. https://doi.org/10.1007/s00044-020-02652-y
Li JJ, Liu Y, Men YL, Li ZJ, Shi YP, Liu XG, et al. Novel hybrid molecules based on disulfides and 1,2,4-triazole as antiproliferative agents. Phosphorus Sulfur Silicon Relat Elem. 2023;198:114–21. https://doi.org/10.1080/10426507.2022.2116638
Acknowledgements
The authors are grateful to the Tianjin Municipal Natural Science Foundation (18JCYBJC94900) for financial support.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Tang, R., Zhao, H., Zhang, S. et al. Synthesis and pharmacological evaluation of new disulfides linked to 1,2,4-triazole bearing urea moiety. Med Chem Res 32, 1736–1748 (2023). https://doi.org/10.1007/s00044-023-03100-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-023-03100-3